3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide

C32H34F3N7O — CID 146293336

About 3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide

3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide (PubChem CID 146293336) has the molecular formula C32H34F3N7O and a molecular weight of 589.67 g/mol. Its IUPAC name is 3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide.

Molecular Properties

• Compound Name: 3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
• PubChem CID: 146293336
• Molecular Formula: C32H34F3N7O
• Molecular Weight: 589.67 g/mol
• Exact Mass: 589.28
• IUPAC Name: 3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
• SMILES: Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nc(C(C)C)n2ccnc(N)c12
• InChI: InChI=1S/C32H34F3N7O/c1-20(2)30-39-27(28-29(36)37-11-12-42(28)30)10-8-22-17-23(6-5-21(22)3)31(43)38-25-9-7-24(26(18-25)32(33,34)35)19-41-15-13-40(4)14-16-41/h5-7,9,11-12,17-18,20H,13-16,19H2,1-4H3,(H2,36,37)(H,38,43)
• InChIKey: GMRGPROGLVTTBZ-UHFFFAOYSA-N
• XLogP: 5.16
• TPSA: 91.79 Ų
• H-Bond Donors: 2
• H-Bond Acceptors: 7
• Rotatable Bonds: 5
• Heavy Atoms: 43
• Complexity: —

Lipinski Rule of Five

2 violations

Rule	Value
MW ≤ 500	589.67
LogP ≤ 5	5.16
H-Bond Donors ≤ 5	2
H-Bond Acceptors ≤ 10	7

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide?

The IUPAC name of 3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide (CID 146293336) is 3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide.

What is the SMILES notation for 3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide?

The canonical SMILES for 3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide is Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nc(C(C)C)n2ccnc(N)c12.

What is the InChIKey of 3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide?

The InChIKey is GMRGPROGLVTTBZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H34F3N7O/c1-20(2)30-39-27(28-29(36)37-11-12-42(28)30)10-8-22-17-23(6-5-21(22)3)31(43)38-25-9-7-24(26(18-25)32(33,34)35)19-41-15-13-40(4)14-16-41/h5-7,9,11-12,17-18,20H,13-16,19H2,1-4H3,(H2,36,37)(H,38,43).

What are the key properties of 3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide?

3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide has a molecular weight of 589.67 g/mol, XLogP of 5.16, 5 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.

Where does this data come from?

All data for 3-[2-(8-amino-3-propan-2-ylimidazo[1,5-a]pyrazin-1-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide is sourced from PubChem (CID 146293336), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).